In collaboration with Phynova, XPH's TCM drug "Cold and Flu Relief Powder for Oral Solution" recieveld Market Approval from MRNA in UK;
Partner with the Chinese Academy of Sciences (GIBH) in building the "Guangdong-Hongkong-Macao Stem Cell Center" ;
XPH and three other enterprises jointly forged the“Guangzhou Federation of Bio-Industry”, with XPH as chair, this federation has gathered more than 120 entities of Guangzhou; including bio-pharmaceutical enterprises, research institutions, universities, and clinical medical institutions;
Optained the first RNAi IND drug approval in China for STP705, a drug co-developed by XPH and Sirnaomics ;
KX02 for the treatment of Gliomas recieved IND drug approval in China.